These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26864615)

  • 1. Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine.
    Kawahara T; Aljarah AK; Shareef HK; Inoue S; Ide H; Patterson JD; Kashiwagi E; Han B; Li Y; Zheng Y; Miyamoto H
    Prostate; 2016 Jun; 76(8):744-56. PubMed ID: 26864615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation.
    Kawahara T; Ide H; Kashiwagi E; Patterson JD; Inoue S; Shareef HK; Aljarah AK; Zheng Y; Baras AS; Miyamoto H
    Am J Cancer Res; 2015; 5(10):2959-68. PubMed ID: 26693052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
    Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle.
    Hennenberg M; Strittmatter F; Beckmann C; Rutz B; Füllhase C; Waidelich R; Montorsi F; Hedlund P; Andersson KE; Stief CG; Gratzke C
    PLoS One; 2012; 7(11):e50904. PubMed ID: 23226423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor knockdown enhances prostate cancer chemosensitivity by down-regulating FEN1 through the ERK/ELK1 signalling pathway.
    Xie W; Li S; Guo H; Zhang J; Tu M; Wang R; Lin B; Wu Y; Wang X
    Cancer Med; 2023 Jul; 12(14):15317-15336. PubMed ID: 37326412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELK1 promotes urothelial tumorigenesis in the presence of an activated androgen receptor.
    Inoue S; Ide H; Mizushima T; Jiang G; Kawahara T; Miyamoto H
    Am J Cancer Res; 2018; 8(11):2325-2336. PubMed ID: 30555747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer.
    Rosati R; Polin L; Ducker C; Li J; Bao X; Selvakumar D; Kim S; Xhabija B; Larsen M; McFall T; Huang Y; Kidder BL; Fribley A; Saxton J; Kakuta H; Shaw P; Ratnam M
    Clin Cancer Res; 2018 Dec; 24(24):6509-6522. PubMed ID: 30185422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells.
    Patki M; Chari V; Sivakumaran S; Gonit M; Trumbly R; Ratnam M
    J Biol Chem; 2013 Apr; 288(16):11047-65. PubMed ID: 23426362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
    Weber H; Ruoff R; Garabedian MJ
    PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth.
    Rosati R; Patki M; Chari V; Dakshnamurthy S; McFall T; Saxton J; Kidder BL; Shaw PE; Ratnam M
    J Biol Chem; 2016 Dec; 291(50):25983-25998. PubMed ID: 27793987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.
    Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Ishiguro H; Miyamoto H
    Prostate; 2015 May; 75(6):573-84. PubMed ID: 25631176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
    Forbes A; Anoopkumar-Dukie S; Chess-Williams R; McDermott C
    Prostate; 2016 Jun; 76(8):757-66. PubMed ID: 26880388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer.
    Pardy L; Rosati R; Soave C; Huang Y; Kim S; Ratnam M
    Prostate; 2020 Feb; 80(2):198-208. PubMed ID: 31794091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat.
    Shimizu S; Shimizu T; Tsounapi P; Higashi Y; Martin DT; Nakamura K; Honda M; Inoue K; Saito M
    PLoS One; 2015; 10(8):e0133798. PubMed ID: 26308715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract.
    Inoue S; Ide H; Fujita K; Mizushima T; Jiang G; Kawahara T; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of α
    Nagata Y; Kawahara T; Goto T; Inoue S; Teramoto Y; Jiang G; Fujimoto N; Miyamoto H
    Am J Cancer Res; 2020; 10(12):4386-4398. PubMed ID: 33415006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.
    Hori Y; Ishii K; Kanda H; Iwamoto Y; Nishikawa K; Soga N; Kise H; Arima K; Sugimura Y
    Cancer Prev Res (Phila); 2011 Jan; 4(1):87-96. PubMed ID: 21205739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.